SEC Form 4 · accession 0001061983-18-000010
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Califf
Director
Period of report
Feb 8, 2018
Accepted (ET)
Feb 12, 2018 · 6:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $8.35 | Feb 8, 2018 | A | 35,000 | A | Mar 8, 2018 | Feb 8, 2028 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1This option shall vest and become exercisable as to 35,000 shares divided into equal monthly installments such that the option shall be 100% vested on February 8, 2021.